GLPwatch
Trials (2081)
Page 13 of 35.
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
- Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly
- Combination Therapy for Alcohol Use Disorder
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
- A Study of LY3502970 in Healthy Participants
- Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
- Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
- The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
- A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
- A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
- Anti-diabetic Drugs and Fatty Liver Management
- Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
- Tirzepatide vs Liraglutide in Bone
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Trial of EXenatide in Acute Ischaemic Stroke
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
- Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)
- A Study of Tirzepatide in Participants With Impaired Liver Function
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
- Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
- A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
- Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity
- A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2
- Study That Tests AD109 in Patients Taking GLP-1 Drugs
- Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
- CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
- Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
- SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
- A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
- Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
- A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
- The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
- A Study in Participants With Type 2 Diabetes Mellitus
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
- LIraglutide and Beta-cell RepAir (LIBRA) Study
- Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Fibrosis Lessens After Metabolic Surgery
- Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
- Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- Free Fatty Acid Effects In Type 2 Diabetes
- GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
- Exenatide and Weight Loss for Diabetes Prevention
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
- Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss